CDC report shows decrease in US tobacco product use

Mar.23.2022
CDC report shows decrease in US tobacco product use
CDC's survey showed a decrease in overall tobacco product usage among American adults, but 19% still use some form of tobacco.

According to foreign media on March 17, 2022, report that...

 

The Centers for Disease Control and Prevention (CDC) released the findings of their weekly report on incidence and mortality rates today, revealing an overall decrease in the use of commercial tobacco products, combustible tobacco products, cigarettes, e-cigarettes, and two or more tobacco products among U.S. adults from 2019 to 2020. However, as of 2020, nearly one-fifth of adults (estimated 47.1 million) reported current (daily or some days) tobacco product use, including 30.8 million smokers.

 

In order to assess recent estimates of tobacco product use among adult Americans aged 18 and over, the Center for Disease Control and Prevention (CDC) analyzed data from the 2020 National Health Interview Survey. The survey evaluated the use of five tobacco products: cigarettes, cigars (cigars, small cigars, or filtered little cigars), pipes (regular pipes, water pipes, or hookahs), electronic cigarettes, and smokeless tobacco.

 

A recent study has found that by 2020, 19.0% of American adults will have used at least one tobacco product, which is slightly lower than the 20.8% reported in 2019. Despite this decrease, cigarettes remain the most commonly used product at 12.5%, followed by e-cigarettes at 3.7%, cigars at 3.5%, smokeless tobacco at 2.3%, and pipes at 1.1%.

 

We have made significant progress in preventing and reducing tobacco use in this country through the use of validated strategies and implementation of effective policies," said Dr. Karen Hacker, director of the CDC's National Center for Chronic Disease Prevention and Health Promotion. "Although adult tobacco use has dramatically decreased, our work is far from over. We must continue to address tobacco-related health disparities and inequities to ensure that everyone has the opportunity to be as healthy as possible.

 

Despite a decrease, the usage of combustible products remains high.

 

A new study reveals that smoking rates among adults have dropped to their lowest point since 1965, when it was 42%. While the percentage of adults who smoke has decreased from 14.0% in 2019 to 12.5% in 2020, nearly 31 million American adults still reported smoking in 2020. Among adults who currently use tobacco products, over three-quarters use combustible products like cigarettes, cigars, and pipes, which are the leading cause of tobacco-related illness, disability, and death in the United States.

 

In the United States, between 2019 and 2020, there was a decrease in the percentage of adults using other tobacco products, including e-cigarettes, which went from 4.5% to 3.7%. The use of combustible tobacco products also decreased from 16.7% to 15.2%. Additionally, the percentage of people using two or more tobacco products also decreased from 3.9% to 3.3%.

 

Factors that may contribute to a decline in smoking and tobacco use include influential anti-tobacco media campaigns such as the CDC's "Tips From Former Smokers," smoke-free policies, and policies that restrict the supply of specific types of tobacco products, such as flavored products.

 

Differences in the use of tobacco products

 

By 2020, significant differences still exist in the use of tobacco products among various adult population groups in the United States. These groups include:

 

Men (5%).

 

Nine percent of adults aged 25 to 44 years old.

 

34.9% of adult non-Hispanic American Indian/Alaska Native individuals and 1% of adult non-Hispanic individuals are classified as belonging to other races.

 

Three percent of adults live in rural (non-urban) areas.

 

The highest level of education attained by adults is a General Educational Development (GED) certificate, which accounts for 40.5%.

 

25.2% of adults have a household annual income less than $35,000.

 

Adults who identify as lesbian, gay, or bisexual (1%).

 

27.3% of adults do not have health insurance, while 6% rely on Medicaid or other forms of subsidized health insurance.

 

Four percent of adults have disabilities.

 

Nearly 30% of adults experience anxiety and 6% experience depression on a regular basis.

 

(Source: Center for Disease Control)

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026 will bring together international experts to discuss European regulation, tax policy, Track & Trace, market access, retail impacts, consumer behavior and innovation. Sessions will also examine Poland’s tobacco-growing perspective and the growing fragmentation of Europe’s tobacco and nicotine market. Media partner 2FIRSTS will host the second “2FIRSTS Connect at InterTabac” on September 16, focusing on developments in China’s tobacco and nicotine industry.
Aug.06
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
According to convenience retail publication CStore Decisions, U.S. convenience store tobacco categories are undergoing a structural shift. Based on Circana OmniMarket Total U.S. Convenience data for the 52 weeks ending June 14, 2026, cigarettes remained the largest category with $50.8 billion in sales, but unit sales declined 5.3%. Electronic smoking devices and vaping products also declined, while modern oral nicotine products continued to grow, with nicotine pouch sales rising 29% in dollars and 17% in units. Retailers said changing consumer preferences are reshaping tobacco product assortments at convenience stores.
Regulations
Aug.07
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04